Dr Silvia Oggero
Post Doctoral Research Assistant
Research
Interests
interest and expertise in all in vitro models which wil mimick inflammation and are crucial in the resolution process in various chronic diseases.Publications
Publications of specific relevance to Predictive in vitro Models2020
Piras G, Rattazzi L, Paschalidis N, Oggero S, Berti G, Ono M, Bellia F, D'Addario C, Dell'Osso B, Pariante CM, Perretti M and D'Acquisto F (2020). Immuno-moodulin: A new anxiogenic factor produced by Annexin-A1 transgenic autoimmune-prone T cells. Brain, Behavior, and Immunity vol. 87, 689-702. 10.1016/j.bbi.2020.02.015Allen BL, Montague-Cardoso K, Simeoli R, Colas RA, Oggero S, Vilar B, McNaughton PA, Dalli J, Perretti M, Sher E and Malcangio M (2020). Imbalance of proresolving lipid mediators in
persistent allodynia dissociated from signs of
clinical arthritis. Lippincott, Williams & Wilkins Pain 10.1097/j.pain.00000000000019082019
Oggero S, Austin-Williams S and Norling LV (2019). The contrasting role of extracellular vesicles in vascular inflammation and tissue repair. Frontiers Media Frontiers in Pharmacology vol. 10, 10.3389/fphar.2019.014792018
Lashin HMS, Nadkarni S, Oggero S, Jones HR, Knight JC, Hinds CJ and Perretti M (2018). Microvesicle Subsets in Sepsis Due to Community Acquired Pneumonia Compared to Faecal Peritonitis. Shock vol. 49, (4) 393-401. 10.1097/SHK.00000000000009892016
Martin L, Horst K, Chiazza F, Oggero S, Collino M, Brandenburg K, Hildebrand F, Marx G, Thiemermann C and Schuerholz T (2016). The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsis. Scientific Reports vol. 6, 10.1038/srep37277